Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with Coronavirus disease 2019 caused by the … PA Christensen, RJ Olsen, SW Long, R Snehal, JJ Davis, MO Saavedra, ... The American Journal of Pathology 192 (4), 642-652, 2022 | 219 | 2022 |
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas PA Christensen, RJ Olsen, SW Long, S Subedi, JJ Davis, P Hodjat, ... The American journal of pathology 192 (2), 320-331, 2022 | 107 | 2022 |
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas PA Christensen, RJ Olsen, SW Long, S Subedi, JJ Davis, P Hodjat, ... MedRxiv, 2021 | 107 | 2021 |
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas JM Musser, PA Christensen, RJ Olsen, SW Long, S Subedi, JJ Davis, ... | 41 | 2021 |
T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns BM Callahan, JM Yavorski, YN Tu, WL Tong, JC Kinskey, KR Clark, ... Cancer Immunology, Immunotherapy 67, 885-892, 2018 | 24 | 2018 |
Recovery of immunoglobulin VJ recombinations from pancreatic cancer exome files strongly correlates with reduced survival JC Kinskey, YN Tu, WL Tong, JM Yavorski, G Blanck Cancer Microenvironment 11, 51-59, 2018 | 21 | 2018 |
Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant … PA Christensen, RJ Olsen, SW Long, R Snehal, JJ Davis, MO Saavedra, ... medRxiv, 2021.12. 30.21268560, 2022 | 18 | 2022 |
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston PA Christensen, RJ Olsen, SW Long, S Subedi, JJ Davis, P Hodjat, ... Texas. medRxiv 2021 (19.21260808), 10.1101, 2021 | 4 | 2021 |
Bacterial sequencing reads in blood exome files from melanoma and cervical cancer patients are associated with cancer recurrence JU Quach, MJ Diaz, TI Huda, JC Kinskey, S Zaman, JE Desantis, KJ Cios, ... Molecular Biotechnology 65 (9), 1476-1484, 2023 | 3 | 2023 |
The presence of intratumoral Porphyromonas gingivalis correlates with a previously defined pancreatic adenocarcinoma, immune cell expression phenotype and … JC Kinskey, TI Huda, EC Gozlan, JU Quach, JF Arturo, A Chobrutskiy, ... Carcinogenesis 44 (5), 411-417, 2023 | 2 | 2023 |
Outcomes Associated with Bacterial Species Detected in Blood Exomes of Melanoma and Cervical Cancer Patients J Quach, M Diaz, T Huda, J Kinskey, S Zaman, J Desantis, K Cios, ... Journal of Biological Chemistry 299 (3), 103094, 2023 | | 2023 |
Rapid Analysis and Integration of Patient Clinical Data with SARS-CoV-2 Genome Sequence Data J Kinskey, J Hsu, J Davis, R Olsen, S Long, P Christensen American Journal of Clinical Pathology 158 (Supplement_1), S16-S17, 2022 | | 2022 |
Reflex-Ordered Molecular Biomarkers in Early-Stage Lung Adenocarcinoma P Hodjat, J Kinskey, J Thomas, FZ Leon-Quintero JOURNAL OF MOLECULAR DIAGNOSTICS 24 (10), S123-S123, 2022 | | 2022 |
Perivascular epithelioid cell tumor in the mediastinum: Metastasis or multiple primaries? JC Kinskey, MR Schwartz, CC Guo, JY Ro Human Pathology Reports 29, 300658, 2022 | | 2022 |
IMMUNOPATHOLOGY AND INFECTIOUS DISEASES PA Christensen, RJ Olsen, SW Long, R Snehal, JJ Davis, MO Saavedra, ... The American Journal of Pathology 192 (4), 2022 | | 2022 |
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas (preprint) JM Musser, PA Christensen, RJ Olsen, SW Long, S Subedi, JJ Davis, ... | | 2021 |
MP61-07 A HIGH 12-CHEMOKINE SCORE IS A FAVORABLE PROGNOSTIC INDICATOR AND SURROGATE MARKER FOR THE PRESENCE OF TERTIARY LYMPHOID STRUCTURES IN BLADDER CANCER L Zemp, J Kinskey, A Hajiran, BJ Manley, PE Spiess, SM Gilbert, ... Journal of Urology 203, e937-e938, 2020 | | 2020 |